Cancer Genetics, Inc. CGIX

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ CAPITAL

Shares	-
Market Cap^[1]	$ 48.7 M
EBITDA (LTM)	-
P/E (LTM)	-
P/S (LTM)	-
EPS (LTM)	-

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.